Preparing for the EU Health Technology Assessment: Key Insights from the Upcoming 2026 Webinar

The European Commission is organizing a webinar set for 15 January 2026 for health technology developers of medicinal products. The event provides guidance on EU Health Technology Assessment (HTA) Regulation prep, focused on Joint Clinical Assessments (JCAs) for certain medicinal products, with topics including dossier submissions, timelines, and EU HTA Coordination Group interactions. Practical sessions will cover regulatory processes, and registration stays open until mid-January 2026.

The EU HTA Regulation (EU) 2021/2282 is key, as endorsed by the European Parliament and Council, and it sets a voluntary framework that evolves to mandatory JCAs with goals including less duplication in HTA and boosting efficiency across 27 member states. See details on official EU Health Technology webpages.